Synapse - Genitourinary Oncology Service

Results (5690)

Combinatorial targeting of oncogenesis via a novel rationally designed Hsp90 inhibitor

Meeting Abstract

Chiosis, G.; Solit, D.; Vilenchik, M.; Rosen, N.
Cancer Research (2004)

17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison

Meeting Abstract

Tse, A. N.; Solit, D.; Rosen, N.; Schwartz, G.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Primary retroperitoneal lymph node dissection (RPLND) for non-seminomatous germ-cell tumor (NSGCT): Impact of trends in patient selection on retroperitoneal pathology and outcome

Meeting Abstract

Stephenson, A. J.; Bosl, G. J.; Motzer, R. J.; Bajorin, D. F.; Stasi, J. P.; Sheinfeld, J.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygaidanamycin)

Meeting Abstract

Solit, D. B.; Egorin, M.; Valentin, G.; Delacruz, A.; Ye, Q.; Schwartz, L.; Larson, S.; Rosen, N.; Scher, H. I.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Update of a phase 1 study of intravenous CCI-779 given in combination with interferon-alpha to patients with advanced renal cell carcinoma

Meeting Abstract

Smith, J. W.; Ko, Y. J.; Dutcher, J.; Hudes, G.; Escudier, B.; Motzer, R.; Negrier, S.; Duclos, B.; Galand, L.; Strauss, L.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

MSKCC Quality Assessment (QA) monitoring program for potentially harmful chemotherapy orders

Meeting Abstract

Sklarin, N. T.; Timoney, J.; Kampel, L.; Hydzik, C.; Savage, J.; Capobianco, M.; Miransky, J.; Haspel, J.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Changing demographics and the contemporary surgical management of renal cortical tumors

Meeting Abstract

Russo, P.; Snyder, M. E.; Rabbani, F.; Kattan, M. W.; Motzer, R.; Reuter, V.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

A phase I dose finding study of weekly, sequential docetaxel (Doc) followed by flavopiridol (F) in patients with advanced solid tumors

Meeting Abstract

Rathkopf, D.; Fornier, M.; Shah, M.; Kortmansky, J.; O'reilly, E.; King, A.; Winkelmann, J.; Kelsen, D. P.; Olsen, S.; Schwartz, G. K.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Phase II trial of cisplatin (C), fixed-dose rate gemcitabine (G) and gefitinib for advanced transitional cell carcinoma (TCC) of the urothelial tract: Preliminary results of CALGB 90102

Meeting Abstract

Philips, G.; Halabi, S.; Sanford, B.; Bajorin, D.; Small, E.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Hormonal induction followed by rapid hormonal cycling for prostate cancer (PC): The MEN's Cycle

Meeting Abstract

Nordquist, L.; Sauter, N.; Morris, M.; Smaletz, O.; Konopelski, K.; Delacruz, A.; Heller, G.; Scher, H. I.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save